Literature DB >> 7191711

Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

M G St John Sutton, J T Lie, K R Anderson, P C O'Brien, R L Frye.   

Abstract

The topography and specificity of fibre disarray and fibrosis in hypertrophic obstructive cardiomyopathy were determined in a histological study comprising 40 necropsy hearts--10 with hypertrophic cardiomyopathy, 10 with congestive cardiomyopathy, 10 with aortic valve stenosis, and 10 normal hearts. Seven standard regional sections were sampled from each heart and graded "double-blind" (tissue location and disease entity) for severity and extent of fibre dissarray and four distinct types of myocardial fibrosis. Statistical comparison of the severity and distribution of indices of fibre disarray and fibrosis within each group and between the normal and the disease groups showed that fibre disarray and fibrosis were qualitatively non-specific for hypertrophic cardiomyopathy. However, when fibre disarray was quantified (1) it was significantly increased in hypertrophic cardiomyopathy and allowed separation of hearts with hypertrophic cardiomyopathy from normal hearts and from those with congestive cardiomyopathy and aortic stenosis, (2) it did not vary significantly among sections of the left ventricle (that is, between the septum and the free wall) in hypertrophic cardiomyopathy, (3) it was closely associated with plexiform fibrosis, and (4) it varied independently of wall and septal thickness. Though the histogenesis of fibre disarray is unknown, it probably represents an exaggeration of a non-specific common pathway for many diverse pathophysiological processes.

Entities:  

Mesh:

Year:  1980        PMID: 7191711      PMCID: PMC482424          DOI: 10.1136/hrt.44.4.433

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  32 in total

1.  Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients.

Authors:  V J Ferrans; A G Morrow; W C Roberts
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

2.  Asymmetric septal hypertrophy (ASH) in infancy.

Authors:  B J Maron; J E Edwards; W L Henry; C E Clark; G J Bingle; S E Epstein
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

3.  Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings.

Authors:  B J Maron; V J Ferrans; W L Henry; C E Clark; D R Redwood; W C Roberts; A G Morrow; S E Epstein
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

Review 4.  Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course.

Authors:  W L Henry; C E Clark; S E Epstein
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

5.  Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis.

Authors:  C E Clark; W L Henry; S E Epstein
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

6.  Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

Authors:  W L Henry; C E Clark; S E Epstein
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

7.  Unusual evolution of acquired infundibular stenosis in patients with ventricular septal defect. Clinical and morphologic observations.

Authors:  B J Maron; V J Ferrans; R I White
Journal:  Circulation       Date:  1973-11       Impact factor: 29.690

8.  Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis.

Authors:  P M Shah; R Gramiak; A G Adelman; E D Wigle
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

9.  Histogenesis of the embryonic myocardium.

Authors:  F J Manasek
Journal:  Am J Cardiol       Date:  1970-02       Impact factor: 2.778

10.  Hypertrophic obstructive cardiomyopathy, a histological, histochemical, and ultrastructural study of biopsy material.

Authors:  S Van Noorden; E G Olsen; A G Pearse
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

View more
  41 in total

1.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 2.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

3.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

4.  Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.

Authors:  C H Thompson; G J Kemp; D J Taylor; M Conway; B Rajagopalan; A O'Donoghue; P Styles; W J McKenna; G K Radda
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy.

Authors:  R Sepp; N J Severs; R G Gourdie
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

7.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

Review 8.  Athlete's heart or hypertrophic cardiomyopathy?

Authors:  Jörg Lauschke; Bernhard Maisch
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

9.  Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.

Authors:  Shingo Kato; Shiro Nakamori; Steven Bellm; Jihye Jang; Tamer Basha; Martin Maron; Warren J Manning; Reza Nezafat
Journal:  Am J Cardiol       Date:  2016-07-18       Impact factor: 2.778

10.  Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.

Authors:  Lian-Ming Wu; Bing-Hua Chen; Qiu-Ying Yao; Yang-Rongzheng Ou; Rui Wu; Meng Jiang; Jiani Hu; Dong-Aolei An; Jian-Rong Xu
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.